Endotelial dysfunction in members of family with familial combined hyperlipidemia;Endoteliální dysfunkce u členů rodin s familiární kombinovanou hyperlipidémií

Vnitrni Lekarstvi

Volumn 49, Issue 8, 2003, Pages 623-629

  Karásek, David ^a,b   Vaverkova H ^a   Hutyra, M ^a   Halenka, M ^a   Novotny D ^a   Budikova M ^b   Slavik L ^c  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c NONE

Author keywords

Adhesive molecules; Endothelial dysfunction; Familial combined hyperlipidemia; Flow mediated dilatation; Inhibitor of plasminogen activator; Von Willebrand factor

Indexed keywords

BIOCHEMICAL MARKER; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN ACTIVATOR INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTERIOSCLEROSIS; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; COHORT ANALYSIS; ECHOGRAPHY; ENDOTHELIUM LESION; FAMILIAL DISEASE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMORAL IMMUNITY; HYPERLIPIDEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MALE; ULTRASOUND;

ADULT; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASODILATION; VON WILLEBRAND FACTOR;

EID: 0041317166     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Anderson, T. J., Uehata, A., Gerhard, M. D.: Close relation of endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cradiol., 26, 1995, 1235-1241
2. Aouizerat, B. E., Allayee, H., Bondar, J. et al.: Novel genes for familial combined hyperlipidemia. Curr. Opin. Lipidol., 10, 1999, 113-122
3. Balletshofer, B. M., Rittig, K., Enderle, M. D. et al.: Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation, 101, 2000, 1780-1784
4. Blann, A. D., Lip, G. Y.: Assessment of endothelial dysfunction using plasma markers. Heart, 78, 1997, 321-322
5. Blann, A. D., Tebrener, D. A.: A reliable marker of endothelial cell dysfunction: Does it exist? Brit. J. Haematol., 12, 1994, 925-928
6. Bredie, S. J. H, van Drongelen, J., Kiemeney, L. A. et al.: Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol., 17, 1997, 834-840
7. Bultas, J., Cífková, R., Češka, R. et al.: Od endoteliální dysfunkce k ischemické chorobé srdeční. 1. vyd. Galén, Praha 1999, 127 s.
8. Celermajer, D. S.: Endothelial dysfunction: Does it matter? Is it reversible? J. Am. Coll. Cardiol., 30, 1997, 325-333
9. Celermajer, D. S., Sorensen, K. E., Georgakopoulos, D. et al.: Cigarette smoking is associated with a dose-related and potentially reversible impairment of endothelium-dependent dilatation in healthy young adults. Circulation, 88, 1993, 2149-2155
10. Celermajer, D. S., Sorensen, K. E., Gooch, V. M. et al.: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340, 1992, 1111-1115
11. Celermajer, D. S., Sorensen, K. E., Spiegelhalter, D. J. et al.: Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J. Am. Coll. Cardiol., 24, 1994, 471-476
12. Clarkson, P., Celermajer, D. S., Powe, A. J. et al.: Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation, 96, 1997, 3378-3383
13. Clarkson, P., Celermajer, D. S., Sampson, M. et al.: Endothelial dysfunction in insulin-dependent diabetes mellitus is related duration and LDL-cholesterol levels. J. Am. Coll. Cardiol., 99, 1996, 99-100
14. Cullen, P., Farren, B., Scott, J. et al.: Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler. Thromb., 14, 1994, 1233-1249
15. Češka, R.: Cholesterol a ateroskleróza. Léčba hyperlipidémií. 2. vyd. Maxdorf, Praha 1999, 226 s.
16. De Graaf, J., Stalenhoef, A. F.: Defects of lipoprotein metabolism in familial combined hyperlipidemia. Curr. Opin. Lipidol., 9, 1998, 189-186
17. De Man, F. H., Weverling-Rijnsburger, A. W. E., van der Laarse, A. et al.: Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilatation. Reversal after lipid-lowering therapy by atorvastatin. Arterioscler. Thromb. Vasc. Biol., 20, 2000, 744-750
18. De Meyer, G. R. Y., Herman, A. G.: Vascular endothelial dysfunction. Progr. Cardiovasc. Dis., 39, 1997, 325-342
19. De Roos, N. M., Bots, M. L., Katan, M. B.: Replacement of dietary saturated fatty acid by trans fatty acid lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler. Thromb. Vasc. Biol., 21, 2001, 1233-1237
20. Demacker, P. N. M., Veerkamp, M. J., Bredie, S. J. H. et al.: Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia. Arteriosclerosis, 153, 2000, 483-490
21. Goldstein, J. L., Schrott, H. G., Hazzard W. R. et al.: Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a now inherited disorder, combined hyperlipidemia. J. Clin. Invest., 52, 1973, 1544-1568
22. Grundy, S. M., Chait, A., Brunzell, J. D.: Familial combined hyperlipidemia workshop. Arteriosclerosis, 7, 1987, 203-207
23. Hashimoto, M., Eto, M., Akishita M. et al.: Correlation between flow - mediated vasodilatation of the brachial artery and intima - media thickness in the carotid artery in men. Arterioscler. Thromb. Vasc. Biol., 19, 1999, 2795-2800
24. Hokanson, J. E., Austin, M. A., Zambon A. et al.: Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler. Thromb., 13, 1993, 427-434
25. Hokanson, J. E., Krauss, R. M., Albers, J. J.: LDL physical and chemical properties in familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol., 15, 1995, 4, 452-459
26. Hornig, B., Maier, V., Drexler, E.: Physical training improves endothelial function in patients with chronic heart failure. Circulation, 93, 1996, 210-214
27. Chowienczyk, P. J., Watts, G. F., Cockfort, J. R. et al.: Impaired endothelium-dependent vasodilatation of forearm resistance vessels in hypercholesterolemia. Lancet, 340, 1992, 1430-1432
28. Chowienczyk, P. J.; Watts, G. F., Wierzbicki, A. S.: Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J. Am. Coll. Cardiol., 29, 1997, 964-968
29. Johnstone, M. T., Creager, S. J., Scales, K. M. et al.: Impaired endothelial-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Ciculation, 88, 1993, 2510-2516
30. Karjalainen, L., Pihlajamäki, J., Karhapää, P. et al.: Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia. A precursor defect for dyslipidemia? Arterioscler. Thromb. Vasc. Biol., 18, 1998, 1548-1553
31. Kvasnička, T., Češka, R., Kvasnička, J. et al.: Ovlivnění endoteliální dysfunkce u nemocných s kombinovanou hyperlipoproteinémií po terapii ciprofibrátem. Interní medicina pro praxi, 9, 2001, 1-4
32. Liang, Y. L., Teede, H., Kotsopoulos, D. et al.: Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Clinical Science, 95, 1998, 669-679
33. Lekakis, J., Papamichael, C., Vemmos, C. et al.: Effects of acute cigarette smoking on endothelium-dependent arterial dilatation in normal subjects. Am. J. Cardiol., 81, 1998, 1225-1228
34. Lieberman, E. H., Gerhard, M. D., Uehata, A.: Estrogen improves endothelium-dependent, flow-mediated vasodilatation in postmenopausal women. Ann. Intern. Med., 121, 1994, 936-941
35. Malik, J., Melenovsky, V., Wichterle, D. et al.: Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial - FAT). Cardiovasc. Res., 52, 2001, 290-298
36. Neunteufl, T., Heher, S., Katzenschlager, R. et al.: Late prognostic value of flow-mediated dilatation in the brachial artery of patients with chest pain. Am. J. Cardiol., 86, 2000, 207-210
37. Panza, J. A., Quyyumi, A. A., Brush, J. E. et al.: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med., 323, 1990, 22-27
38. Pitha, J., Roztočil, K., Cífková, R. et al.: Endoteliální dysfunkce a její hodnocení. Cor Vasa, 43, 2001, 452-456
39. Pitkänen, O. P., Nuutila, P., Raitakari, O. T. et al.: Coronary flow reserve in young men with familial combined hyperlipidemia. Circulation, 99, 1999, 1678-1684
40. Raitakari, O. T., Celermajer, D. S.: Flow mediated dilatation. Br. J. Clin. Pharmacol., 50, 2000, 397-404
41. Sorensen, K. E., Celermajer, D. S., Georgakopoulos, D. et al.: Impairment of endothelium-dependent dilatation is an early event in children with familial hypercholestrolemia and is related to the lipoprotein (a) level. J. Clin. Invest., 93, 1994, 50-55
42. Sorensen, K. E., Celermajer, D. S., Spiegelhalter, D. J., et al.: Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br. Heart. J., 74, 1995, 247-253
43. Stroes, E., de Bruin, T., de Valk, H. et al.: NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants. Cardiovasc. Res., 36, 1997, 445-452
44. Šimon, J. et al.: Epidemiologie a prevence ischemické choroby srdeční, 1.vyd. Grada Publishing, Praha 2001, 264 s.
45. Vaverková, H., Weinbergová, O., Horčička, V. et al.: Rodinná kombinovaná hyperlipidemie. I. Rozmanitost lipoproteinového obrazu. Vnitř. Lék., 32, 1986, 878-886
46. Vaverková, H., Weinbergová, O., Horčička, V. et al.: Rodinná kombinovaná hyperlipidemie. II. Riziko ischemické choroby srdeční. Vnitř. Lék., 32, 1986, 887-893
47. Veerkamp, M. J., de Graaf, J., Bredie, S. J. et al.: Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of 5-year follow-up study. Arterioscler. Thromb. Vasc. Biol., 22, 2002, 274-282
48. Venkatesan, S., Cullen, P., Pacy, P. et al.: Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler. Thromb., 13, 1993, 1110-1118
49. Vogel, R. A.: Brachial artery ultrasound: A noninvasive tool in the assessment of triglyceride-rich lipoproteins. Clin. Cardiol., 22, 1999, suppl. II, 34-39
50. Woo, K. S., Chook, P., Lolin, Y. I. et al.: Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans. Circulation, 96, 1997, 2542-2297